Peripheral Arteryโ Disease Linked to Accelerated Breast Cancer Growth: A Summary
Researchโข from NYU Grossman School of โMedicine reveals a concerning link between peripheral artery โdisease (PAD) and increased breast cancer โgrowth.The study demonstrates that restricted โblood flow (ischemia) triggers changes inโข the โคimmune โคsystem, creating an โhabitat more tolerant to cancer.
Key Findings:
Immune System Reprogramming: Ischemia causes a โshift in stem cells within the bone marrow,โฃ leading toโ an increase in immune โฃcells that suppress inflammation (myeloid cells) and a decrease in those that promote anti-tumorโ responsesโ (lymphocytes, especially T cells). Thisโฃ mirrors immune โchanges seen โwith โaging.
Tumor Microenvironment Shift: The environment within tumors also becomes more immune-suppressive, accumulating cells that shield cancer from attack.
Long-Lasting Changes: โ These immune alterations aren’t temporary. Ischemia causes lastingโ changes inโค gene expression and even the structure of chromatin (DNA scaffolding),making it harder for immune cells to fight cancer.
Mechanism of Action: The study used a โฃmouseโ model to show thatโ ischemia directly drives cancer growth byโ reprogrammingโฃ stemโ cells and promoting immune โtolerance.
Implications &โ Future Research:
Thisโข research highlights โคthe importance of addressing cardiovascular and metabolic risk factors as part of a comprehensiveโค cancer treatment strategy. โ Researchers suggest potential โคstrategies โขinclude:
Earlier cancer screening for patients withโฃ PAD. Utilizingโ inflammation-modulating therapies to counteract โขthe effects โof โคischemia on theโค immune system. โ
The team is now working to design clinical studies to evaluate the effectiveness of existing โinflammation-targeted therapies โin combating post-ischemic tumor growth.
Funding Sources: The study was supported by grants from the American โHeart Association and theโ National Institutes of Health, as well as funding โฃfrom the Sarnoff Cardiovascular Research โฃFoundation, the LeDucq Foundation Network,โ and the Laura and Isaac Perlmutter Cancer Center.